FRX fundamentals
FENNEC PHARMACEUTICALS INC earnings per share and revenue
FRX earnings per share for the last quarter are -0.09 CAD whereas the estimation was -0.19 CAD which accounts for 53.43% surprise. Company revenue for the same period amounts to 11.38 M CAD despite the estimated figure of 11.20 M CAD. Estimated earnings per share for the next quarter are -0.20 CAD, and revenue is expected to reach 11.91 M CAD. Also watch annual changes over time to get a bigger picture of FRX earnings per share and revenue dynamics.
Next report date
≈
Report periodQ1 2025
EPS estimate−0.20CAD
Revenue estimate11.91 MCAD
EPS
Forecast
Q1 '20
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
Q4 '25
−0.60
−0.30
0.00
0.30
0.60
Reported
Estimate
Currency: CAD
Q1 '20
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
Q4 '25
Reported
−0.31
−0.28
−0.10
−0.14
0.56
−0.27
−0.29
−0.09
—
—
—
—
Estimate
−0.27
−0.21
−0.16
−0.02
−0.08
−0.03
−0.12
−0.19
−0.20
−0.15
0.15
0.10
Surprise
−13.41%
−33.78%
+40.65%
−453.98%
+817.93%
−717.51%
−136.58%
+53.43%
—
—
—
—
Revenue
Forecast
Q1 '20
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
Q4 '25
0.00
9.00 M
18.00 M
27.00 M
36.00 M
Reported
Estimate
Currency: CAD
Q1 '20
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
Q4 '25
Reported
2.26 M
4.44 M
8.89 M
13.18 M
34.63 M
10.02 M
9.67 M
11.38 M
—
—
—
—
Estimate
2.49 M
4.97 M
7.20 M
11.77 M
13.83 M
15.17 M
12.30 M
11.20 M
11.91 M
13.61 M
23.12 M
22.46 M
Surprise
−9.38%
−10.59%
+23.54%
+11.92%
+150.32%
−33.94%
−21.37%
+1.59%
—
—
—
—